Cell No. : Cell Name
RCB0284 : Sq-1979
update : 2022/03/09
|
| Comment | Metastatic epithelial cell |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Ando, Koichi
|
| Originator |
Majima, Hideyuki
|
| Year of deposit |
1989
|
| Original cell |
NR-S1
|
| Animal |
_mouse
< Mammals
|
| Strain name |
C3H/He
|
| Tissue |
cheek
|
| Disease name |
carcinoma planoepitherial
|
| Classification |
cancer
|
| History |
Mycoplasma was decontaminated
|
| Memo_1 |
Mycoplasma was eliminated with MC-210.
|
|
Lifespan |
infinite
|
| Morphology |
epithelial-like
|
| Cellosaurus(Expasy) |
CVCL_6541
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Culture medium |
|
MEM + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
| SC frequency |
|
Subculture : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma |
|
(-)
|
| SSLP(mouse) |
|
OK
|
| Isozyme |
|
LD, NP
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
1
|
| User's Publication |
12
|
| User's Publication |
|
21629
Machida T, Sakuma K, Fuwa N, Tanaka A.
Local Low-dose Anti-PD-L1 Antibodies Improve Antitumor Effects in Oral Squamous Cell Carcinoma.
Anticancer Res
2024
44(3):993-1002
PubMed ID: 38423636
DOI: 10.21873/anticanres.16894
|
|
17186
Sakuma K, Kii T, Takahashi H, Suzuki S, Yoshikawa K, Ogawa T, Tanaka A.
An In Vivo Study of Local Administration of Low-dose Anti-PD-1 Antibody Using an Oral Cancer Cell Line
Anticancer Res
2022
42(9):4293-4303
PubMed ID: 36039414
DOI: 10.21873/anticanres.15929
|
|
20961
Horii T, Orikawa Y, Ohira Y, Eta R, Kobayashi N, Sato T, Watanabe T, Tanaka T.
Potential of Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, as a hot tumor inducer.
Cancer Cell Int
2022
22(1):392
PubMed ID: 36494701
DOI: 10.1186/s12935-022-02821-6
|
|
20202
Matsunami A, Mizuno-Kamiya M, Kawaki H, Takayama E, Ueno K, Ando M, Morimoto-Ito H, Muramatsu Y, Sumitomo S, Kondoh N.
Augmented secretion of IL-1α from mouse oral squamous cell carcinoma (OSCC) cells caused by serum deprivation and hypoxia promotes immune suppressive activity of mesenchymal stromal cells.
J Oral Biosci
2021
PubMed ID: 34153475
DOI: 10.1016/j.job.2021.06.001
|
|
11681
Hiroe Morimoto-Ito, Masako Mizuno-Kamiya, Naoki Umemura, Yoshinori Inagaki, Eiji Takayama, Harumi Kawaki, Yasunori Muramatsu, Shinichiro Sumitomo, Nobuo Kondoh
Immunosuppressive Effect of Mesenchymal Stromal Cells is Enhanced by IL-1α from Oral Squamous Cell Carcinoma Cells
The Open Dentistry Journal
2019
13:221-227
DOI: 10.2174/1874210601913010221
|
|
10705
Adachi M, Mizuno-Kamiya M, Takayama E, Kawaki H, Inagaki T, Sumi S, Motohashi M, Muramatsu Y, Sumitomo SI, Shikimori M, Yamazaki Y, Kondoh N.
Gene expression analyses associated with malignant phenotypes of metastatic sub-clones derived from a mouse oral squamous cell carcinoma Sq-1979 cell line.
Oncol Lett
2018
15:3350-3356
PubMed ID: 29435078
DOI: 10.3892/ol.2017.7648
|
|
11047
Suppressive effect of mesenchymal stromal cells on interferon-γ-producing capability of spleen cells was specifically enhanced through humoral mediator(s) from mouse oral squamous cell carcinoma Sq-1979 Cells In Vitro
Cancer Translational Medicine
2018
4, 9-16
DOI: 10.4103/ctm.ctm_34_17
|
|
11026
The producing capabilities of Interferon-γ and Interleukin-10 of spleen cells in primary and metastasized oral squamous cell carcinoma cells-implanted mice
Cancer Transl Med
2017
3:194–9
DOI: 10.4103/ctm.ctm_30_17
|
|
14354
Sumi S, Umemura N, Takayama E, Ohkoshi E, Adachi M, Mizuno-Kamiya M, Inagaki T, Kawaki H, Sumitomo S, Kondoh N.
Metastasized murine oral squamous cell carcinoma cells induce intratumoral polymorphonuclear myeloid derived suppressor cells
Oncol Rep
2017
37(5):2897-2904
PubMed ID: 28405677
DOI: 10.3892/or.2017.5575
|
|
18749
Li X, Bukawa H, Hirota M, Tsuyuki Y, Omura S, Fujita K.
Novel OK-432-conjugated tumor vaccines induce tumor-specific immunity against murine tongue cancer
J Dent Res
2003
82(8):636-4
PubMed ID: 12885850
DOI: 10.1177/154405910308200813
|
|
17923
Matsumoto K, Saga Y, Ikemura T, Sakakura T, Chiquet-Ehrismann R.
The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
J Cell Biol
1994
125(2):483-93
PubMed ID: 7512972
DOI: 10.1083/jcb.125.2.483
|
|
17890
Saga Y, Tsukamoto T, Jing N, Kusakabe M, Sakakura T.
Murine tenascin: cDNA cloning, structure and temporal expression of isoforms
Gene
1991
104(2):177-85
PubMed ID: 1717349
DOI: 10.1016/0378-1119(91)90248-a
|
Back
Top
CELL BANK Website
